바로가기메뉴

본문 바로가기 주메뉴 바로가기

Late Respiratory Infection after Lung Transplantation

Tuberculosis & Respiratory Diseases / Tuberculosis & Respiratory Diseases,
2013, v.74 no.2, pp.63-69
Sang Young Kim (Yonsei University College of Medicine)









  • Downloaded
  • Viewed

Abstract

Background: Aiming to improve outcome of lung transplantation (LTx) patients, we reviewed risk factors and treatment practices for the LTx recipients who experienced respiratory infection in the late post-LTx period (>1 month after LTx). Methods: We analyzed the clinical data of 48 recipients and donors from 61 LTx, who experienced late respiratory infections. Late respiratory infections were classified according to the etiology, time of occurrence, and frequency of donor-to-host transmission or colonization of the recipient prior to transplantation. Results: During the period of observation, 42 episodes of respiratory infections occurred. The organisms most frequently involved were gram (−) bacteria: Acinetobacter baumannii (n=13, 31.0%), Pseudomonas aeruginosa (n=7, 16.7%), and Klebsiella pneumoniae (n=4, 10.0%). Among the 42 episodes recorded, 14 occurred in the late post-LTx period. These were bacterial (n=6, 42.9%), fungal (n=2, 14.3%), viral (n=4, 28.5%), and mycobacterial (n=2, 14.3%) infections. Of 6 bacterial infections, 2 were from multidrug-resistant (MDR) A. baumannii and one from each of MDR P. aeruginosa, extended spectrum β-lactamase (+) K. pneumoniae, methicillin-resistant Staphylococcus aureus and Streptococcus pneumoniae. Infection-related death occurred in 6 of the 14 episodes (43%). Conclusion: Although the frequency of respiratory infection decreased sharply in the late post-LTx period, respiratory infection was still a major cause of mortality. Gram (−) MDR bacteria were the agents most commonly identified in these infections.

keywords
Lung Transplantation, Respiratory Tract Infections

Reference

1.

Christie JD, Edwards LB, Kucheryavaya AY, Benden C, Dobbels F, Kirk R, et al. The Registry of the International Society for Heart and Lung Transplantation: twenty-eighth adult lung and heart-lung transplant report 2011. J Heart Lung Transplant 2011;30:1104-22.

2.

Horvath J, Dummer S, Loyd J, Walker B, Merrill WH, Frist WH. Infection in the transplanted and native lung after single lung transplantation. Chest 1993;104:681-5.

3.

Maurer JR, Tullis DE, Grossman RF, Vellend H, Winton TL, Patterson GA. Infectious complications following isolated lung transplantation. Chest 1992;101:1056-9.

4.

Paradis IL, Williams P. Infection after lung transplantation. Semin Respir Infect 1993;8:207-15.

5.

Chaparro C, Maurer JR, Chamberlain D, De Hoyos A, Winton T, Westney G, et al. Causes of death in lung transplant recipients. J Heart Lung Transplant 1994;13: 758-66.

6.

Aguilar-Guisado M, Givalda J, Ussetti P, Ramos A, Morales P, Blanes M, et al. Pneumonia after lung transplantation in the RESITRA Cohort: a multicenter prospective study. Am J Transplant 2007;7:1989-96.

7.

Campos S, Caramori M, Teixeira R, Afonso J Jr, Carraro R, Strabelli T, et al. Bacterial and fungal pneumonias after lung transplantation. Transplant Proc 2008;40: 822-4.

8.

Dummer JS, Montero CG, Griffith BP, Hardesty RL, Paradis IL, Ho M. Infections in heart-lung transplant recipients. Transplantation 1986;41:725-9.

9.

Deusch E, End A, Grimm M, Graninger W, Klepetko W, Wolner E. Early bacterial infections in lung transplant recipients. Chest 1993;104:1412-6.

10.

Husain S, Chan KM, Palmer SM, Hadjiliadis D, Humar A, McCurry KR, et al. Bacteremia in lung transplant recipients in the current era. Am J Transplant 2006;6: 3000-7.

11.

Burguete SR, Maselli DJ, Fernandez JF, Levine SM. Lung transplant infection. Respirology 2013;18:22-38.

12.

Zamora MR. Cytomegalovirus and lung transplantation. Am J Transplant 2004;4:1219-26.

13.

Duncan AJ, Dummer JS, Paradis IL, Dauber JH, Yousem SA, Zenati MA, et al. Cytomegalovirus infection and survival in lung transplant recipients. J Heart Lung Transplant 1991;10(5 Pt 1):638-44.

14.

Soghikian MV, Valentine VG, Berry GJ, Patel HR, Robbins RC, Theodore J. Impact of ganciclovir prophylaxis on heart-lung and lung transplant recipients. J Heart Lung Transplant 1996;15:881-7.

15.

Zuk DM, Humar A, Weinkauf JG, Lien DC, Nador RG, Kumar D. An international survey of cytomegalovirus management practices in lung transplantation. Transplantation 2010;90:672-6.

16.

Ruttmann E, Geltner C, Bucher B, Ulmer H, Hofer D, Hangler HB, et al. Combined CMV prophylaxis improves outcome and reduces the risk for bronchiolitis obliterans syndrome (BOS) after lung transplantation. Transplantation 2006;81:1415-20.

17.

Chmiel C, Speich R, Hofer M, Michel D, Mertens T, Weder W, et al. Ganciclovir/valganciclovir prophylaxis decreases cytomegalovirus-related events and bronchiolitis obliterans syndrome after lung transplantation. Clin Infect Dis 2008;46:831-9.

18.

Zamora MR, Nicolls MR, Hodges TN, Marquesen J, Astor T, Grazia T, et al. Following universal prophylaxis with intravenous ganciclovir and cytomegalovirus immune globulin, valganciclovir is safe and effective for prevention of CMV infection following lung transplantation. Am J Transplant 2004;4:1635-42.

19.

Jaksch P, Zweytick B, Kerschner H, Hoda AM, Keplinger M, Lang G, et al. Cytomegalovirus prevention in high-risk lung transplant recipients: comparison of 3- vs 12-month valganciclovir therapy. J Heart Lung Transplant 2009;28:670-5.

20.

Hamacher J, Spiliopoulos A, Kurt AM, Nicod LP. Preemptive therapy with azoles in lung transplant patients. Geneva Lung Transplantation Group. Eur Respir J 1999;13:180-6.

21.

Reichenspurner H, Gamberg P, Nitschke M, Valantine H, Hunt S, Oyer PE, et al. Significant reduction in the number of fungal infections after lung-, heart-lung, and heart transplantation using aerosolized amphotericin B prophylaxis. Transplant Proc 1997;29:627-8.

22.

Calvo V, Borro JM, Morales P, Morcillo A, Vicente R, Tarrazona V, et al. Antifungal prophylaxis during the early postoperative period of lung transplantation. Valencia Lung Transplant Group. Chest 1999;115:1301-4.

23.

Hosseini-Moghaddam SM, Husain S. Fungi and molds following lung transplantation. Semin Respir Crit Care Med 2010;31:222-33.

24.

Dromer C, Nashef SA, Velly JF, Martigne C, Couraud L. Tuberculosis in transplanted lungs. J Heart Lung Transplant 1993;12(6 Pt 1):924-7.

25.

Malouf MA, Glanville AR. The spectrum of mycobacterial infection after lung transplantation. Am J Respir Crit Care Med 1999;160(5 Pt 1):1611-6.

26.

Chalermskulrat W, Sood N, Neuringer IP, Hecker TM, Chang L, Rivera MP, et al. Non-tuberculous mycobacteria in end stage cystic fibrosis: implications for lung transplantation. Thorax 2006;61:507-13.

27.

Paciocco G, Martinez FJ, Kazerooni EA, Bossone E, Lynch JP 3rd. Tuberculous pneumonia complicating lung transplantation: case report and review of the literature. Monaldi Arch Chest Dis 2000;55:117-21.

28.

Morales P, Briones A, Torres JJ, Sole A, Perez D, Pastor A. Pulmonary tuberculosis in lung and heart-lung transplantation: fifteen years of experience in a single center in Spain. Transplant Proc 2005;37:4050-5.

29.

Korea Centers for Disease Control and Prevention. 2011 Annual report on the notified tuberculosis patients in Korea. Seoul: Korea Centers for Disease Control and Prevention; 2011.

30.

Trulock EP, Edwards LB, Taylor DO, Boucek MM, Keck BM, Hertz MI. The Registry of the International Society for Heart and Lung Transplantation: twenty-first official adult lung and heart-lung transplant report 2004. J Heart Lung Transplant 2004;23:804-15.

31.

Zenati M, Dowling RD, Dummer JS, Paradis IL, Arena VC, Armitage JM, et al. Influence of the donor lung on development of early infections in lung transplant recipients. J Heart Transplant 1990;9:502-8.

32.

Weill D, Dey GC, Hicks RA, Young KR Jr, Zorn GL Jr, Kirklin JK, et al. A positive donor Gram stain does not predict outcome following lung transplantation. J Heart Lung Transplant 2002;21:555-8.

33.

Avlonitis VS, Krause A, Luzzi L, Powell H, Phillips JA, Corris PA, et al. Bacterial colonization of the donor lower airways is a predictor of poor outcome in lung transplantation. Eur J Cardiothorac Surg 2003;24:601-7.

Tuberculosis & Respiratory Diseases